ArteraAI Employee Directory
Hospitals and Health CareCalifornia, United States51-200 Employees
ArteraAI operates in the hospital and health care sector, developing AI-driven tests that prognosticate patient outcomes and personalize treatment decisions for prostate cancer. The company builds prognostic and predictive biomarkers from data drawn from five Phase III randomized trials, with the aim of helping clinicians identify which patients are most likely to benefit from specific therapies. A component of its approach involves incorporating digital pathology data to inform decision-making. Headquartered in Los Altos, California, the firm is a mid-sized provider focused on delivering prognostic insights to support cancer care decisions. In June 2026, it announced the clinical availability of the ArteraAI Prostate Test for metastatic hormone-sensitive prostate cancer, a digital pathology-based prognostic test intended to inform treatment planning.